Status:

ACTIVE_NOT_RECRUITING

Preemer Trial - Prophylactic Mesh Versus no Mesh in the Midline Emergency Laparotomy Closure for Prevention of Incisional Hernia: a Multi Center, Double-blind, Randomized Controlled Trial

Lead Sponsor:

University of Oulu

Collaborating Sponsors:

Helsinki University Central Hospital

Conditions:

Incisional Hernia

Emergency Laparotomy

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

244 patients, who have an emergency midline laparotomy for any gastrointestinal reason, will be randomized in a 1:1 ratio either to mesh group with a retrorectus prophylactic self-gripping mesh or to ...

Detailed Description

Incisional hernia (IH) is a common complication of abdominal wall surgery. Its' incidence varies greatly (2-30 %) among studies. The incisional hernia incidence is influenced by several factors, such ...

Eligibility Criteria

Inclusion

  • Midline emergency laparotomy for any gastrointestinal indication

Exclusion

  • • Previous ventral hernia repair with mesh in the midline
  • Previous inguinal or femoral hernia repair by any technique with mesh is accepted
  • Previous WHO class of physical activity 3-4 (WHO 3 more than 50% of time at rest, WHO 4 stays at rest most of the time)
  • Relaparotomy
  • Indication for laparotomy is incarcerated hernia
  • Pregnant or suspected pregnancy
  • \<18 years
  • Metastastic malignancy of any origin
  • Planned osteomyelitis
  • Patients living geographically distant and/or unwilling to return for follow-ups
  • No informed consent
  • Subject participates in another RCT Intra-operative exclusion criteria applicable for both randomization groups
  • Abdomen is left open
  • Second look laparotomy planned
  • Ostomy created at the operation
  • Inability to keep the mesh securely out of the peritoneal cavity or close the anterior fascia
  • Intra-abdominal malignancy diagnosed at the operation
  • \>2 cm hernia in midline

Key Trial Info

Start Date :

April 27 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2028

Estimated Enrollment :

109 Patients enrolled

Trial Details

Trial ID

NCT04311788

Start Date

April 27 2020

End Date

March 1 2028

Last Update

February 1 2024

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Jorvi Hospital

Espoo, Finland

2

Helsinki University Hospital

Helsinki, Finland

3

Lahti Central Hospital

Lahti, Finland

4

Oulu University Hospital

Oulu, Finland